StockData
IceCure Medical Ltd. logo

IceCure Medical Ltd. (ICCM) stock

ICCMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 17, 2026Score 2/30
$0.83+0.07 (+9.21%)

Close on Nov 17, 2026Market cap $2.84MP/E 0.1Yield –

IceCure Medical r&d expenses

Research and development expenses are spending on new products and technology.

For fiscal 2025 it was $7.43M, up 4.7% from the year before. The highest annual figure on record is $9.12M in fiscal 2022.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$7.43M+4.7%
FY2024Dec 31, 2024$7.10M-14.2%
FY2023Dec 31, 2023$8.27M-9.3%
FY2022Dec 31, 2022$9.12M+55.2%
FY2021Dec 31, 2021$5.88M+54.3%
FY2020Dec 31, 2020$3.81M+26.9%
FY2019Dec 31, 2019$3.00M–

More IceCure Medical figures

See a number that looks wrong?